These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32692703)

  • 1. Utility and duration of leuprolide stimulation testing in children.
    Nijjar JK; Weiss JJ; Misra M; Stanley TL
    J Pediatr Endocrinol Metab; 2020 Jul; ():. PubMed ID: 32692703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gonadotropin and Estradiol Levels after Leuprolide Stimulation Tests in Brazilian Girls with Precocious Puberty.
    Junqueira FR; Lara LA; Martins WP; Ferriani RA; Rosa-E-Silva AC; de Sá MF; Reis RM
    J Pediatr Adolesc Gynecol; 2015 Oct; 28(5):313-6. PubMed ID: 26094907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of gonadotrophin suppression in girls treated with GnRH analogue for central precocious puberty; validity of single luteinizing hormone measurement after leuprolide acetate injection.
    Demirbilek H; Alikasifoglu A; Gonc NE; Ozon A; Kandemir N
    Clin Endocrinol (Oxf); 2012 Jan; 76(1):126-30. PubMed ID: 21790701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated Pre-injection Basal Luteinizing Hormone Concentrations are Common in Girls Treated for Central Precocious Puberty.
    Schubert S; Hvelplund AH; Handberg A; Hagstroem S; Leunbach TL
    J Clin Res Pediatr Endocrinol; 2021 Jun; 13(2):204-211. PubMed ID: 33374097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between luteinizing hormone and estradiol secretion in female precocious puberty: evaluation by sensitive gonadotropin assays and the leuprolide stimulation test.
    Garibaldi LR; Aceto T; Weber C; Pang S
    J Clin Endocrinol Metab; 1993 Apr; 76(4):851-6. PubMed ID: 8473395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring treatment of central precocious puberty using basal luteinizing hormone levels and practical considerations for dosing with a 3-month leuprolide acetate formulation.
    Lee PA; Luce M; Bacher P
    J Pediatr Endocrinol Metab; 2016 Nov; 29(11):1249-1257. PubMed ID: 27740929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pelvic ultrasonography in the evaluation of central precocious puberty: comparison with leuprolide stimulation test.
    Sathasivam A; Rosenberg HK; Shapiro S; Wang H; Rapaport R
    J Pediatr; 2011 Sep; 159(3):490-5. PubMed ID: 21489559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single sample GnRHa stimulation test in the diagnosis of precocious puberty.
    Yazdani P; Lin Y; Raman V; Haymond M
    Int J Pediatr Endocrinol; 2012 Jul; 2012(1):23. PubMed ID: 22809285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Diagnostic Utility of the Basal Luteinizing Hormone Level and Single 60-Minute Post GnRH Agonist Stimulation Test for Idiopathic Central Precocious Puberty in Girls.
    Cao R; Liu J; Fu P; Zhou Y; Li Z; Liu P
    Front Endocrinol (Lausanne); 2021; 12():713880. PubMed ID: 34456870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-year results of treatment with depot leuprolide acetate for central precocious puberty.
    Neely EK; Hintz RL; Parker B; Bachrach LK; Cohen P; Olney R; Wilson DM
    J Pediatr; 1992 Oct; 121(4):634-40. PubMed ID: 1403402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of leuprolide acetate response patterns in the early diagnosis of pubertal disorders: comparison with the gonadotropin-releasing hormone test.
    Ibáñez L; Potau N; Zampolli M; Virdis R; Gussinyé M; Carrascosa A; Saenger P; Vicens-Calvet E
    J Clin Endocrinol Metab; 1994 Jan; 78(1):30-5. PubMed ID: 7507123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 36-month treatment experience of two doses of leuprolide acetate 3-month depot for children with central precocious puberty.
    Lee PA; Klein K; Mauras N; Lev-Vaisler T; Bacher P
    J Clin Endocrinol Metab; 2014 Sep; 99(9):3153-9. PubMed ID: 24926950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase 3 Trial of a Small-volume Subcutaneous 6-Month Duration Leuprolide Acetate Treatment for Central Precocious Puberty.
    Klein KO; Freire A; Gryngarten MG; Kletter GB; Benson M; Miller BS; Dajani TS; Eugster EA; Mauras N
    J Clin Endocrinol Metab; 2020 Oct; 105(10):e3660-71. PubMed ID: 32738042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Random unstimulated pediatric luteinizing hormone levels are not reliable in the assessment of pubertal suppression during histrelin implant therapy.
    Neely EK; Silverman LA; Geffner ME; Danoff TM; Gould E; Thornton PS
    Int J Pediatr Endocrinol; 2013 Dec; 2013(1):20. PubMed ID: 24295437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spontaneous serum gonadotropin concentrations in the evaluation of precocious puberty.
    Neely EK; Wilson DM; Lee PA; Stene M; Hintz RL
    J Pediatr; 1995 Jul; 127(1):47-52. PubMed ID: 7608810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The usefulness of the leuprolide stimulation test as a diagnostic method of idiopathic central precocious puberty in girls.
    Carretto F; Salinas-Vert I; Granada-Yvern ML; Murillo-Vallés M; Gómez-Gómez C; Puig-Domingo M; Bel J
    Horm Metab Res; 2014 Dec; 46(13):959-63. PubMed ID: 25295414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic value of urinary luteinizing hormone levels in the monitoring of precocious puberty treatment.
    Yüce Ö; Bideci A; Çelik N; Çamurdan O; Cinaz P
    Arch Endocrinol Metab; 2020 Apr; 64(2):121-127. PubMed ID: 32236310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of depot leuprolide acetate dose-adequacy for central precocious puberty.
    Cook JS; Doty KL; Conn PM; Hansen JR
    J Clin Endocrinol Metab; 1992 May; 74(5):1206-9. PubMed ID: 1569169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of leuprolide acetate 3-month depot 11.25 milligrams or 30 milligrams for the treatment of central precocious puberty.
    Lee PA; Klein K; Mauras N; Neely EK; Bloch CA; Larsen L; Mattia-Goldberg C; Chwalisz K
    J Clin Endocrinol Metab; 2012 May; 97(5):1572-80. PubMed ID: 22344198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unstimulated Luteinizing Hormone for Assessment of Suppression during Treatment of Central Precocious Puberty with 6-Month Subcutaneous Leuprolide Acetate: Correlations with Clinical Response.
    Klein KO; Miller BS; Mauras N
    Horm Res Paediatr; 2024 Apr; ():1-10. PubMed ID: 38684152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.